288 related articles for article (PubMed ID: 18579711)
1. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
[TBL] [Abstract][Full Text] [Related]
2. Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice.
Sun J; Zhao Y; Jin H; Hu J
Int Immunopharmacol; 2015 Apr; 25(2):235-41. PubMed ID: 25682767
[TBL] [Abstract][Full Text] [Related]
3. Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.
Canavese M; Altruda F; Silengo L; Castiglioni V; Scanziani E; Radaelli E
Histol Histopathol; 2011 Mar; 26(3):285-96. PubMed ID: 21210341
[TBL] [Abstract][Full Text] [Related]
4. Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation.
Wen J; Pei H; Wang X; Xie C; Li S; Huang L; Qiu N; Wang W; Cheng X; Chen L
J Dermatol Sci; 2014 Jun; 74(3):242-50. PubMed ID: 24685902
[TBL] [Abstract][Full Text] [Related]
5. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells control VEGF-dependent skin inflammation.
Teige I; Hvid H; Svensson L; Kvist PH; Kemp K
J Invest Dermatol; 2009 Jun; 129(6):1437-45. PubMed ID: 19037231
[TBL] [Abstract][Full Text] [Related]
7. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
[TBL] [Abstract][Full Text] [Related]
8. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.
Ren X; Li J; Zhou X; Luo X; Huang N; Wang Y; Chen X; Wei Y
Dermatology; 2009; 219(3):232-8. PubMed ID: 19729876
[TBL] [Abstract][Full Text] [Related]
9. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.
Singh TP; Schön MP; Wallbrecht K; Gruber-Wackernagel A; Wang XJ; Wolf P
PLoS One; 2013; 8(1):e51752. PubMed ID: 23335955
[TBL] [Abstract][Full Text] [Related]
10. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
11. Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse.
Chen T; Zhang LW; Fu LX; Wu YB; Liu XY; Guo ZP
Clin Exp Dermatol; 2017 Dec; 42(8):849-856. PubMed ID: 28597992
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
[TBL] [Abstract][Full Text] [Related]
14. VEGF-A promotes IL-17A-producing γδ T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells.
Suzuki T; Hirakawa S; Shimauchi T; Ito T; Sakabe J; Detmar M; Tokura Y
J Dermatol Sci; 2014 May; 74(2):116-24. PubMed ID: 24485663
[TBL] [Abstract][Full Text] [Related]
15. The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis.
Chen L; Marble DJ; Agha R; Peterson JD; Becker RP; Jin T; Li J; Chan LS
Microcirculation; 2008 Jan; 15(1):49-64. PubMed ID: 17952801
[TBL] [Abstract][Full Text] [Related]
16. IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation.
Wang X; Sun J; Hu J
PLoS One; 2015; 10(12):e0145498. PubMed ID: 26691862
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
18. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL
Oncogene; 1998 Jul; 17(3):303-11. PubMed ID: 9690512
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice.
Tarutani M; Imai Y; Yasuda K; Tsutsui H; Nakanishi K; Yamanishi K
J Dermatol Sci; 2010 Apr; 58(1):28-35. PubMed ID: 20188517
[TBL] [Abstract][Full Text] [Related]
20. A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis.
Yan HX; Wang Y; Yang XN; Fu LX; Tang DM
Mol Med Rep; 2013 Aug; 8(2):434-8. PubMed ID: 23732650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
